Georges has 30 years of experience in the biopharmaceutical industry, including management and executive positions. Georges has been Enterome’s Chairman since 2015.  He previously held leadership positions such as President and CEO of Altus Pharmaceuticals and Executive Vice President of Genzyme Corporation where he was responsible for the company’s global therapeutics businesses. Prior to that, he served as Vice President of the US Specialty Care Business for Hoffmann-La Roche and as General Manager of Hoffmann-La Roche Portugal. He also serves as Chairman of the Board of Orphazyme, Gemini Therapeutics, Dynacure, and is on the Board of Supernus Pharmaceuticals.

Georges received his PharmD from St. Joseph University and his PhD in Pharmacology from Paris-Sud University.